Showing results (201-210 of 229) with videos related to

Sort By:
Pageof 23
Annals of Hepatology|May 18, 2019
Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV CarriersConar R O'Neil, Stephen E Congly, M Sarah Rose, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 30, 2019
Efficacy of a Peruvian Botanical Remedy (Sabell A4+) for Treating Liver Disease and Protecting Gastric Mucosal IntegrityMark G Swain, John L Wallace, D Lorne Tyrrell, et al.
NPJ Vaccines|January 12, 2021
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)Shivali S Joshi, Rachelle P Davis, Mang M Ma, et al.
Gastrointestinal Endoscopy|November 5, 2016
Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaksApostolos V Tsolakis, Paul D James, Gilaad G Kaplan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2008
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Paul Marotta, et al.
The Journal of Investigative Dermatology|February 27, 2017
Depression Is Associated with an Increased Risk of Psoriatic Arthritis among Patients with Psoriasis: A Population-Based StudyRyan T Lewinson, Isabelle A Vallerand, Mark W Lowerison, et al.
Pharmacoeconomics|March 12, 2003
Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis CJens Rasenack, Stefan Zeuzem, S Victor Feinman, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 29, 2021
Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, CanadaAbdel Aziz Shaheen, Kristine Kong, Christopher Ma, et al.
Gastroenterology|July 20, 2010
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirinMark G Swain, Ming-Yang Lai, Mitchell L Shiffman, et al.
Frontiers in Immunology|April 20, 2019
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center StudyGary L Norman, Anna Reig, Odette Viñas, et al.
Pageof 23